Sammaan Capital Regulatory Approval

Debt & Borrowing

Sammaan Capital Debt & Borrowing: ₹0.06 Cr

Sammaan Capital certified timely monthly interest payments on two listed secured NCD series, totalling about ₹5.73 lakh. The filing confirms servicing of existing debt rather than new borrowing.

Value

₹0.06 Cr

Debt & Borrowing

Sammaan Capital Debt & Borrowing: ₹0.11 Cr

Sammaan Capital certified timely payment of ₹10.70 lakh interest on two listed secured NCD series due October 2026. No redemption was made.

Value

₹0.11 Cr

Debt & Borrowing

Sammaan Capital Debt & Borrowing: ₹0.08 Cr

Sammaan Capital confirmed timely payment of interest on secured NCDs. Interest paid totals about ₹8.42 lakh, or 0.08 Crore, across two ISINs.

Value

₹0.08 Cr

Debt & Borrowing

Sammaan Capital Debt & Borrowing: ₹0.54 Cr

Sammaan Capital certified timely interest payment of about Rs. 0.54 Crore across nine listed secured NCD ISINs on 27 October 2026. No delay or non-payment was reported.

Value

₹0.54 Cr

Debt & Borrowing

Sammaan Capital Debt & Borrowing: ₹0.38 Cr

Sammaan Capital certified timely interest payment on six secured NCD series. Total interest paid is about Rs.0.38 Crore.

Value

₹0.38 Cr

Debt & Borrowing

Sammaan Capital Debt & Borrowing: ₹0.02 Cr

Sammaan Capital certified timely interest payment on its secured NCDs for two ISINs. Interest paid totals about Rs.0.02 Crore.

Value

₹0.02 Cr

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.